Form 4 · Filed May 21, 2026, 09:07 PM UTC
CRBP/Corbus Pharmaceuticals Holdings, Inc.
Kung Winston — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 19, 2026 | A | other | 3,800 | $0 | — | 14,166 |
| May 19, 2026 | A | other | 12,300 | — | — | 12,300 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-234860